Article info
PDFSpoken sessions
Randomised clinical trials in COPD
S50 Once-daily glycopyrronium improves lung function in COPD patients: pooled results of the GLOW1 and GLOW2 studies
Citation
S50 Once-daily glycopyrronium improves lung function in COPD patients: pooled results of the GLOW1 and GLOW2 studies
Publication history
- First published November 19, 2012.
Online issue publication
September 01, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.